Mechanisms of progressive glomerulosclerosis and tubulointerstitial fibrosis

[1]  S. E. Thomas,et al.  Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. , 1998, Kidney international.

[2]  S. E. Thomas,et al.  Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. , 1998, Journal of the American Society of Nephrology : JASN.

[3]  W. Couser,et al.  Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. , 1998, Kidney international.

[4]  C. Murry,et al.  Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. , 1998, The American journal of pathology.

[5]  Y. Sugisaki,et al.  Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. , 1997, The American journal of pathology.

[6]  T. Hostetter,et al.  Interaction of angiotensin II and TGF-beta 1 in the rat remnant kidney. , 1997, Journal of the American Society of Nephrology : JASN.

[7]  G. Remuzzi,et al.  Role of increased glomerular protein traffic in the progression of renal failure. , 1997, Kidney international. Supplement.

[8]  I. Pawluczyk,et al.  Macrophages promote prosclerotic responses in cultured rat mesangial cells: a mechanism for the initiation of glomerulosclerosis. , 1997, Journal of the American Society of Nephrology : JASN.

[9]  N. Hotta,et al.  Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. , 1997, The American journal of pathology.

[10]  S. E. Thomas,et al.  Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. , 1997, Kidney international.

[11]  M. Cooper,et al.  Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system , 1997 .

[12]  M. Reed,et al.  SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. , 1996, Kidney international.

[13]  A. Eddy.  Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia. , 1996, Kidney international.

[14]  W. Kriz.  Progressive renal failure--inability of podocytes to replicate and the consequences for development of glomerulosclerosis. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  E. Rollo,et al.  Differential effects of osteopontin on the cytotoxic activity of macrophages from young and old mice , 1996, Immunology.

[16]  B. Brenner,et al.  The hyperfiltration theory: a paradigm shift in nephrology. , 1996, Kidney international.

[17]  L. Gesualdo,et al.  Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. , 1996, Journal of the American Society of Nephrology : JASN.

[18]  S. Friedman,et al.  Differential expression of transforming growth factor-β isoforms and receptors in experimental membranous nephropathy , 1996 .

[19]  A. Eddy.  Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. , 1996, Kidney international. Supplement.

[20]  M. Fujishima,et al.  Role of endothelin as a mitogen in experimental glomerulonephritis in rats. , 1996, Kidney international.

[21]  Ping Wang,et al.  The Effect of Dietary Protein Restriction on the Progression of Diabetic and Nondiabetic Renal Diseases , 1996, Annals of Internal Medicine.

[22]  M. Reed,et al.  SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro. , 1996, The American journal of pathology.

[23]  D. Lacey,et al.  Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. , 1996, The American journal of pathology.

[24]  C. Alpers,et al.  Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. , 1996, Kidney international.

[25]  G. Striker,et al.  Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. , 1996, The Journal of clinical investigation.

[26]  W. Couser,et al.  Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. , 1995, Kidney international.

[27]  G. Remuzzi,et al.  Fluid shear stress modulates surface expression of adhesion molecules by endothelial cells. , 1995, Blood.

[28]  K. Lemley,et al.  Structure-stabilizing forces in the glomerular tuft. , 1995, Journal of the American Society of Nephrology : JASN.

[29]  J. Hughes,et al.  Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. , 1994, The Journal of clinical investigation.

[30]  S. Schultz-Cherry,et al.  Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. , 1994, The Journal of biological chemistry.

[31]  S. Suchard,et al.  Role of thrombospondin in mesangial cell growth: possible existence of an autocrine feedback growth circuit. , 1994, Kidney international.

[32]  C. Alpers,et al.  Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. , 1994, Journal of the American Society of Nephrology : JASN.

[33]  R. Johnson,et al.  The glomerular response to injury: progression or resolution? , 1994, Kidney international.

[34]  C. Alpers,et al.  Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). , 1994, The American journal of pathology.

[35]  H. Gröne,et al.  The role of lipids in nephrosclerosis and glomerulosclerosis. , 1994, Atherosclerosis.

[36]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[37]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .

[38]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[39]  W. Border,et al.  Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. , 1992, Kidney international.

[40]  G. Remuzzi,et al.  Thrombospondin induces glomerular mesangial cell adhesion and migration. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[41]  F. Dumler,et al.  Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. , 1992, The Journal of clinical investigation.

[42]  C. Alpers,et al.  Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[43]  R. Atkins,et al.  T cells and macrophages and their role in renal injury. , 1992, Seminars in nephrology.

[44]  K. Schärer,et al.  Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture. , 1992, Kidney international.

[45]  C. Alpers,et al.  Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor , 1992, The Journal of experimental medicine.

[46]  C. Alpers,et al.  Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[47]  C. Alpers,et al.  Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. , 1992, Kidney international.

[48]  C. Alpers,et al.  Increased synthesis of extracellular matrix in mesangial proliferative nephritis. , 1991, Kidney international.

[49]  A. Gown,et al.  Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. , 1991, The Journal of clinical investigation.

[50]  G. Remuzzi,et al.  Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? , 1990, Kidney international.

[51]  M. Sporn,et al.  Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 , 1990, Nature.

[52]  C. Alpers,et al.  Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. , 1990, The American journal of pathology.

[53]  A. Fogo,et al.  Evidence for the central role of glomerular growth promoters in the development of sclerosis. , 1989, Seminars in nephrology.

[54]  B. Brenner,et al.  Chronic effects of dietary protein in the rat with intact and reduced renal mass. , 1986, Kidney international.

[55]  B. Brenner,et al.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. , 1986, The Journal of clinical investigation.

[56]  B. Brenner,et al.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. , 1985, The Journal of clinical investigation.

[57]  B. Brenner,et al.  Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. , 1982, The New England journal of medicine.

[58]  H. Genant,et al.  Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis. , 1982, The New England journal of medicine.

[59]  W. Mitch,et al.  A SIMPLE METHOD OF ESTIMATING PROGRESSION OF CHRONIC RENAL FAILURE , 1976, The Lancet.

[60]  S. Klahr,et al.  Pathogenesis of the glomerulopathy associated with renal infarction in rats. , 1976, Kidney international.

[61]  森田 良樹.  The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis , 1999 .

[62]  R. Atkins,et al.  A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. , 1998, Proceedings of the Association of American Physicians.

[63]  D. Power,et al.  Adhesion molecule interactions in human glomerulonephritis: importance of the tubulointerstitium. , 1996, Kidney international.

[64]  N. Kashihara,et al.  Apoptosis in glomerular sclerosis. , 1996, Kidney international.

[65]  M. Wehrmann,et al.  Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. , 1996, Kidney & blood pressure research.

[66]  C. Alpers,et al.  The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: the glomerular cytokine theory. , 1995, Mineral and electrolyte metabolism.

[67]  W. Couser,et al.  Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation? , 1994, Kidney international. Supplement.

[68]  G. Beck,et al.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. , 1994, The New England journal of medicine.

[69]  A Bohle,et al.  Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. , 1987, American journal of nephrology.

[70]  M. Black.  Letter: Cryostat sections in immunological studies of cancer. , 1973, Lancet.